Perspective Therapeutics (CATX) Operating Leases (2019 - 2026)
Perspective Therapeutics recorded quarterly Operating Leases of $1.6 million in Q1 2026, up 54.43% quarter-over-quarter from $1.0 million in Q4 2025, and up 32.2% year-over-year from $1.2 million in Q1 2025.
Perspective Therapeutics' Operating Leases history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Operating Leases rose 32.2% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 32.2% YoY), while the FY2025 annual figure was $1.0 million, down 29.62% from the prior year.
- Operating Leases came in at $1.6 million for Q1 2026 at Perspective Therapeutics, up from $1.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.7 million in Q3 2024 to a low of $44000.0 in Q1 2023.
- A 5-year average of $941625.0 and a median of $1.0 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases slumped 86.42% in 2023 and surged 2256.82% in 2024, its largest moves.
- Perspective Therapeutics' Operating Leases stood at $186000.0 in 2022, then soared by 319.35% to $780000.0 in 2023, then soared by 83.08% to $1.4 million in 2024, then declined by 29.62% to $1.0 million in 2025, then jumped by 54.43% to $1.6 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $1.6 million, $1.0 million, and $971000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 780,000.00 |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 543,000.00 |
| Mar 31, 2023 | 44,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 324,000.00 |
| Dec 31, 2021 | 392,000.00 |
| Sep 30, 2021 | 715,000.00 |
| Jun 30, 2021 | 524,000.00 |
| Mar 31, 2021 | 838,000.00 |
| Dec 31, 2020 | 897,000.00 |
| Sep 30, 2020 | 956,000.00 |
| Jun 30, 2020 | 769,000.00 |
| Mar 31, 2020 | 830,000.00 |
| Dec 31, 2019 | 889,000.00 |
| Sep 30, 2019 | 948,000.00 |